Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall fentanylThe latest Duragesic patch defect issue has resulted in the February 2008 recall of the dermal patches by the parent pharmaceutical company, Johnson & Johnson. Duragesic dermal patches are designed to deliver the narcotic drug fentanyl to patients with chronic pain, and the patches have been the subject of four other recalls over the past 14 years. The Duragesic patch defect may harm patch wearers and other individuals who come into contact with a defective patch.
Fentanyl Patch
The fentanyl patch defects have been seen before; the internal reservoir that holds the gel-form fentanyl in the patch is defective, with a cut that lets the fentanyl leak out. The fentanyl reservoir of some patches has a cut due to a manufacturing problem. Direct contact with fentanyl, which is a Schedule II narcotic 80 times stronger than morphine, can cause severe breathing difficulties and death.
Hundreds of people in the U.S. have died from fentanyl overdoses. Johnson & Johnson is facing more than 70 lawsuits based on fentanyl patch defects.
Recall Issued
The U.S. Food and Drug Administration (FDA) has issued numerous warnings and alerts about Duragesic patch defects, Johnson & Johnson agreed to recall the defective Duragesic patches at the FDA’s urging.
Duragesic patches are sold by PriCara, a unit of Johnson & Johnson, and by Sandoz, a unit of the pharmaceutical company Novartis. Duragesic patches with a December 2009 or earlier expiration date, sold in the U.S. and Canada, are the subject of the latest recall.
A Dangerous Narcotic
Duragesic patches are most commonly prescribed for cancer patients and others who have developed a tolerance to strong narcotic pain medications. The 25-microgram Duragesic patches that are the subject of the recall are designed to provide about 72 hours of pain relief for a patch wearer.
Your Legal Rights
Whether you have been prescribed the Duragesic dermal patch for cancer pain or another reason, you may have concerns about the Duragesic patch defect and the latest recall. You can learn more about your legal rights when you contact an attorney experienced in product liability law.
Actavis Inc. has expanded its recent recall of fentanyl painkiller patches to include all lots sold in the United States. The company said the expansion is a precautionary measure because it cannot guarantee that all patches are without defect.
Another fentanyl patch recall was issued on Monday over a defect that could cause the patches to leak. This is the second recall issued for the prescription patches in the p...
Approximately 32 million fentanyl-containing pain patches are being recalled by Johnson & Johnson over a manufacturing flaw that could lead to unintentional overdose.
The patches, sold under the brand name » Read More